Top Markets
Coin of the day
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Peringkat dalam Saham #32249
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Harga Saham
$0.8013
Terakhir disinkronkan: 2026-08-05
Kapitalisasi Pasar
$10.62M
Perubahan (1 hari)
0.97%
Perubahan (1 tahun)
-37.88%
Negara
US
Perdagangan Hoth Therapeutics, Inc. (HOTH)

Kategori

Riwayat hasil dividen untuk Hoth Therapeutics, Inc. (HOTH)
Hasil dividen (TTM) dari Hoth Therapeutics, Inc. (simbol saham: HOTH) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Hoth Therapeutics, Inc. (HOTH) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing